This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

SleepMed And Watermark Medical Merge To Deliver Integrated Sleep Care Management To Millions Of Americans Suffering From Sleep Disorders

WEST PALM BEACH, Fla. and COLUMBIA, S.C., April 11, 2013 /PRNewswire/ -- SleepMed, Inc., the largest private sleep diagnostics and therapy provider and Watermark Medical, the leading home sleep technology services company for the diagnosis and treatment of sleep breathing disorders, announce the merger of their companies. Operating under the SleepMed name, the united strengths of SleepMed and Watermark Medical combine to establish a business uniquely poised to address the sleep issues affecting millions of Americans and establish the first national high performing sleep health system.

The merger of SleepMed and Watermark Medical is an important development for the future of the sleep industry and the delivery of sleep related services. Utilizing Watermark's leading edge technology enabled platform and Enterprise relationships and SleepMed's stellar team of sleep experts and hospital partners, the new SleepMed will address the issues associated with the diagnosis and treatment of the widespread sleeping disorders in the U.S.  

Through its combined current annual patient population of over 200,000 patients and its estimated 15,000 independent physician and hospital network partners, the new SleepMed will offer sleep services (i.e. patient engagement integration tools and patient "wellness" products) focused on improving quality sleep via an integrated health-systems company that delivers a continuum of sleep care. As sleep health is a part of a patient's overall health profile, the new SleepMed will embrace and support "Community Sleep Management."  This encourages local expertise, diagnostic pathways and appropriate therapy coordinated by SleepMed.  SleepMed University educational and clinical activities will advance sleep awareness to physicians, employers, other providers, and the general population throughout these healthcare "Sleep Communities."

"Healthcare is changing rapidly and wellness-oriented technology drives efficiencies that will promote the cost-effective solutions that will be adopted and will lower healthcare costs in the coming years," said John Sculley, Chairman. "Sleep disorders continue to be grossly underdiagnosed. The new SleepMed organization will help Americans achieve optimized sleep treatment for life by facilitating care that is accessible, appropriate, and effective."

It is estimated that approximately 40 million Americans suffer from sleep breathing disorders, and recent estimates show that one in five Americans sleep less than six hours per night. If sleep deprivation is ongoing and persistent, it can lead to an increased risk for serious, chronic health problems, such as obesity, diabetes, and heart disease. For example, obstructive sleep apnea (OSA), a life-threatening condition in which breathing stops and then restarts re-currently during sleep, affects approximately 20 million Americans, but is often undiagnosed and untreated. The sleep disorder management industry is estimated to be a $24 billion a year industry.

"Bringing SleepMed and Watermark Medical together represents a dramatic shift in the sleep business and underscores the radical, disruptive change technology is bringing to healthcare today," said Sean Heyniger, CEO. "The new SleepMed will emphasize the delivery of patient-centered quality based sleep services through an integrated offering unmatched in the industry. The ability to integrate the use of technology to improve diagnostic outcomes coupled with the expertise to manage and track patient compliance to the appropriate treatment is the future of sleep medicine."

Increasingly, large employer and insurance companies are recognizing the important role sleep plays in overall health, considering appropriate corporate sleep policies, and evaluating testing and treatment options that are both effective and economic. The sleep disorder management industry is expected to grow significantly as the relationship of patient sleep quality to overall health and wellness is further understood.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 16,058.35 -469.68 -2.84%
S&P 500 1,913.85 -58.33 -2.96%
NASDAQ 4,636.1050 -140.4030 -2.94%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs